（Last updated : 2020-05-09 10:32:32）
DKK3 knockdown confers negative effects on the malignant potency of head and neck squamous cell carcinoma cells via the PI3K/Akt and MAPK signaling pathways.
DKK3 Overexpression Increases Malignant Properties of Head and Neck Squamous Cell Carcinoma Cells.
Evaluation of pancreatic cancer cell migration with multiple parameters in vitro by using an optical real-time cell mobility assay device
A Prospective Observational Study of Adoptive Immunotherapy for Cancer Using Zoledronate-Activated Killer (ZAK) Cells - An Analysis for Patients with Incurable Pancreatic Cancer.
Current Cancer Immunotherapy Using Activated Lymphocytes -Do Lymphocytes Actually Recognize Cancer Cells?
Cyclin-Dependent Kinase Activity Correlates with the Prognosis of Patients Who Have Gastrointestinal Stromal Tumors
Imatinib Plasma Levels during Successful Long-Term Treatment of Metastatic Gastrointestinal Stromal Tumors
Gastrointestinal stromal tumors with exon 8 c-kit gene mutation might occur at extragastric sites and have metastasis-prone nature
Adoptive immunotherapy using autologous lymphocytes activated ex vivo with antigen stimulation for patients with incurable cancer
Metformin suppresses sonic hedgehog expression in pancreatic cancer cells
Eicosapentaenoic Acid Modifies Cytokine Activity and Inhibits Cell Proliferation in an Oesophageal Cancer Cell Line
Characterization of novel germline c-kit gene mutation, KIT-Tyr553Cys, observed in a family with multiple gastrointestinal stromal tumors
Induction of Dihydropyrimidine Dehydrogenase Expression by Mitomycin C in Colorectal Cancer
Lower esophageal sphincter- and vagus-preserving proximal partial gastrectomy for early cancer of the gastric cardia.
In vitro detection of cross-resistant and non-cross-resistant agents with fluorouracil for patients with colorectal cancer.
Surgical oncotaxis--excessive surgical stress and postoperative complications contribute to enhancing tumor metastasis, resulting in a poor prognosis for cancer patients.
Display 5 items
Poor prognosis of hypermutant colorectal cancer with KRAS mutations: A retrospective analysis of 1,052 Japanese colorectal cancer patients without treatment of immuno-checkpoint inhibitors
Efficacy of Ramucirumab in combination with second-line or salvage-line FOLFIRI in patients with metastatic colorectal cancer.
Clinico-pathological features of hypermutant colorectal cancers analyzed over 1000 colorectal cancer
Heat shock protein 90 (HSP90) inhibitor as a candidate treatment option for gastrointestinal stromal tumor with acquired resistance for conventional receptor tyrosine kinase inhibitors
Distinct Clinico-pathological Features of Hypermutant Colorectal Cancers with POLE Pathogenic Mutations, Lynch Syndrome and Sporadic MSI Analyzed over 1,000 Colorectal Cancer Patients
Migration of Pancreatic Cancer cell BxPC-3 is suppressed by ROS
Knockdown of DKK3 gene reduces malignant properties of oral squamous cell carcinoma-derived cells
Heat shock protein 90 inhibitors suppress PDGFRA reactivation and other receptor tyrosine kinase activation important in drug resistant gastrointestinal stromal tumors.
Exploring serum factors for evoking and promoting cancer metastasis
HSP90 inhibitor inhibit the activation of proliferation, chemotaxis and EMT in pancreatic cancer cells
HSP90 inhibitor inhibit the activation of multiple kinase pathways and migration of pancreatic
Imatinib plasma levels and clinical features of successful long-term treatment of metastatic gastrointestinal stromal tumors
Successful treatment of everolimus for a renal impairment patient with neuroendocrine tumor
Functional analyses of DKK3 in oral squamous cell carcinoma cell lines
HSP90 inhibitor inhibit the activation of multiple kinase pathways of pancreatic cancer cells
Suppressing pancreatic cancer metastasis by small molecular compunds
The new molecular target therapy of Hsp90 inhibition in esophageal squamous cell carcinoma
Basic research for inhibiting pancreatic cancer metastasis: Gemcitabine vs Dasatinib
Effect of HSP90 inhibitor on proliferation and migration in esophageal squamous cell carcinoma
Antitumor effect of HSP90 inhibitor against esophageal cancer
Clinicopathological study of gastrointestinal neuroendocrine tumor.
Possibility of combination therapy of molecular targeted drugs for gastrointestinal stromal tumor.
Antitumor effect of Hsp90 inhibitor in neuroendocrine tumor
Wnt signaling during transition from cell proliferation to differentiation in myoblast cells.
Wnt signaling involved in gastrointestinal neuroendocrine tumors.
Cancer vaccine in combination with Anti-CD25 antibody for advanced esophageal squamous cell carcinoma. –a case of the prolonged stable disease
A case with postoperative bone metastasis of gastrointestinal stromal tumor (GIST) expressing exon 8 mutation of KIT
Cancer Vaccine in Combination with Anti-CD25 Antibody for Advanced Esophageal Squamous Cell Carcinomas –A Case of the Prolonged Stable Disease-
Antitumor effect and signaling mechanism of tranilast in gastric cancer cell lines.
Interaction of Wnt4 with myostatin signaling during myogenic differentiation of skeletal muscle.
Different beta-catenin immunoexpression in gastrointestinal neuroendcrine tumors (carcinoid tumors).
Nuclear expression of beta-catenin in oral leukoplakia with or without dysplasia
A pilot study of combined chemotherapy with docetaxel and nedaplatin as a second line for unresectable or recurrent esophageal carcinoma
Excessive surgical stress of thoraco-laparotomy contributes to enhancing tumor metastasis and poor prognosis(surgical or stress oncotaxis)
How to control cytokine storm after thoraco-laparotomy, experimentally and clinically
Technique and results of LES/vagus nerve-preserving proximal partial gastrectomy for cardia cancer
Determination of a second-line chemotherapy agent for patients with colorectal cancer (CRC) after fluorouracil failure
Duplication of common bile duct: A review of the literature
Inflammatory pseudotumor of the spleen: report of three cases
Cender differences in the dihydropyrimidine dehydrogenase(DPD) expression and 5-fluorouracil (5-FU) sensitivity of colorectal cancers (CRCs).
Display 5 items
Japan Society of Clinical Oncology
Japan Surgical Society
Japanese Cancer Association
Japanese Gastric Cancer Association
Japanese Society for Palliative Medicine
Japanese Society of Medical Oncology
The Japanese Gastroenterological Association
Display 5 items
© 2008 Kawasaki Medical School